How to Tell Whether a Peptide Serum Will Actually Work
A cosmetic chemist's guide to the science of penetration, concentration, and formulation - everything brands don't tell you, decoded.
Why Peptides Deserve a Smarter Conversation
If you’ve spent any time in a Sephora or scrolling through social media online, you’ll have encountered peptides: listed on serums, creams, and essences with varying degrees of ceremony, from a single modest mention on the back label to a bold front-of-pack claim about “50 bio-active peptides working in synergy.”
You’ll also have encountered two equally unhelpful responses to these claims: breathless enthusiasm that treats peptides as a cure-all, or dismissive cynicism that writes off the entire category as marketing.
The truth, as it usually is in cosmetic science, is more interesting than either position.
Peptides are genuinely among the most scientifically coherent active ingredient categories in skincare when formulated correctly. They are also one of the most commonly misused, misrepresented, and misunderstood.
This guide aims to equip you with the helpful analytical tools you need to easily tell the difference, not by memorising a list of approved ingredients, but by understanding the underlying science well enough to confidently evaluate any peptide product you come across.
I’ll warn you upfront: some of what follows will challenge things you’ve read elsewhere, including some commonly repeated claims from within the evidence-based skincare community itself. Where the science is settled, I’ll be direct. Where it’s genuinely contested or incomplete, I’ll tell you that too. Intellectual honesty is more useful to you than false certainty in either direction.
What a Peptide Is, and Why That Matters ( Very Briefly )
A peptide is a chain of amino acids, fewer than fifty, by convention, linked by peptide bonds. Proteins are simply longer versions of the same thing. Collagen is a protein; its smaller fragments are peptides. The smaller size matters because your skin has a tough outer layer designed to keep most things out. Peptides, being smaller, have a realistic chance of penetrating deeper, though this isn’t guaranteed. Actual uptake depends on a peptide’s size, charge, chemistry, and crucially, how the product is formulated.
The more important point is what peptides do once inside. They’re not passive structural material, they’re signalling molecules. Skin uses short amino acid sequences as molecular messengers: a fragment of degraded collagen, for instance, signals fibroblasts to produce new collagen and elastin. Cosmetic peptides exploit this system, mimicking or triggering these signals to influence cellular behaviour.
This reframes the entire category. You’re not feeding your skin collagen, you’re sending it a message. Whether that message is received, and what it says, is what the rest of this piece is about.
Matrikines: The Skin’s Repair System, and Peptides Know How to Trigger It
Before we classify cosmetic peptides, we need to understand the biological language they’re trying to speak. That language is the matrikine system, and understanding it is the key to understanding why peptides can actually work.
Your skin’s deeper layer ( the dermis ) is built around a structural scaffold called extracellular matrix ( ECM ) - a dynamic network of collagen fibres, elastin, fibronectin, laminin, and proteoglycans that keeps skin firm and elastic. Cells called fibroblasts are responsible for maintaining it.
But fibroblasts can’t physically “see” when the matrix is damaged. They rely on molecular signals to tell them when repairs are needed. Those signals are matrikines: tiny protein fragments released when collagen and elastin break down. When fibroblasts detect them, they respond by producing new collagen, elastin, and other repair proteins.
In younger skin, this cycle hums along: damage triggers signals, signals trigger repair, and balance is maintained. With age, the enzymes that degrade collagen become more active, fibroblasts become fewer and less responsive, and their sensitivity to repair signals diminishes, resulting in a slow, steady net loss of collagen and elastin.
Cosmetic signal peptides are designed to mimic matrikines, essentially sending the “repair now” message to prompt fibroblasts into action, without waiting for actual damage to occur.
This is the biological logic underneath the marketing. It’s not magic, but it’s not made up either. The question is whether a specific peptide, in a specific product, actually delivers that signal effectively. That’s what we’ll look at next.
The Two Most Evidence-Backed Matrikines Examples
Palmitoyl Pentapeptide-4 (sold as Matrixyl) is a synthetic fragment of procollagen, specifically the KTTKS sequence that your body naturally releases during collagen turnover. In lab studies, it stimulates production of collagen I, III, and fibronectin in fibroblasts; in a double-blind clinical trial, it significantly reduced fine lines vs placebo over 12 weeks. The palmitoyl group attached to it isn’t biological; it’s a formulation trick to help the peptide cross the skin’s lipid barrier.
GHK ( glycine-histidine-lysine ) is naturally present in human plasma and skin, where it acts as a repair signal. Levels decline significantly with age, from around 200 ng/ml at 20 to roughly 80 ng/ml by 60, which correlates with slower tissue repair. In both lab and clinical studies, topical GHK-Cu has been shown to increase collagen and elastin synthesis, improve skin density and firmness, and restore some activity to ageing fibroblasts.
What gives these two more credibility than most cosmetic peptides is that they’re not speculative new mechanisms; they replicate signalling pathways that already exist in the body and are well characterised in the research literature.
Beyond Collagen: Elastin Signals
Elastin breakdown generates its own class of matrikines, called elastokines. The best studied is VGVAPG, which binds to the elastin receptor complex on skin cells and can stimulate elastin synthesis and fibroblast activity. Some cosmetic formulations include peptides designed to mimic this pathway, and early clinical data are promising, but the overall evidence base here is considerably thinner than for collagen-targeting peptides. Treat elastin-focused claims with more scrutiny until more robust trial data emerges.
The Four Classes of Cosmetic Peptides
The biggest mistake in peptide education is treating all peptides as interchangeable, but they are not. Different classes operate via different mechanisms, target different sites, and have different skin-depth requirements. Recognising a product's class helps decide if it suits your goal.
Signal Peptides: Stimulating Production
Signal peptides activate skin repair by mimicking damaged tissue fragments, prompting fibroblasts to produce collagen and elastin. Some also influence keratinocytes, which send signals to deeper fibroblasts, meaning these peptides don't always need to penetrate deeply to produce a real effect. And in fact, many topical peptides will struggle to reach fibroblasts through intact skin and may exert part of their effects indirectly via keratinocyte-fibroblast signalling.
Matrixyl (palmitoyl pentapeptide-4) is the most evidence-backed signal peptide in skincare. It mimics a fragment naturally broken off from procollagen, the precursor to mature collagen, and stimulates production of collagen I, III, and fibronectin. In a 12-week double-blind, placebo-controlled trial in 93 women, just 0.005% in a moisturiser produced significant wrinkle reduction vs. placebo. An earlier 28-day study using 0.005% found measurable decreases in fold depth (18%), fold thickness (37%), and skin rigidity (21%). This is a genuinely solid evidence base by cosmetic ingredient standards.
Matrixyl 3000 combines two matrikines: palmitoyl tripeptide-1 (Pal-GHK), which promotes collagen renewal via TGF-β signalling, and palmitoyl tetrapeptide-7 (Pal-GQPR), which suppresses UV-triggered inflammation by reducing IL-6.
A key formulation note: Matrixyl 3000 stock solution contains these peptides at ~100 ppm and ~50 ppm, respectively. When a product uses 3–5% of that concentrate, the actual peptide concentration is in the low single-digit ppm range. This sounds tiny, but it reflects how potent signalling molecules are at threshold doses.
Matrixyl Synthe’6 (palmitoyl tripeptide-38) takes a broader approach, stimulating six ECM components at once: collagens I, III, and IV, fibronectin, hyaluronic acid, and laminin, acting across both the epidermis and dermis.
Tetrapeptide-21 (GEKG) is newer and mimics a sequence shared by collagen I, III, IV, V, elastin, and fibronectin, with in vitro data showing simultaneous upregulation of all of them alongside MMP-1 suppression. The mechanism is coherent, but most published data come from lab studies or supplier-backed research rather than independent clinical trials, promising, but not yet in the same evidence tier as Matrixyl.
***Interestingly, in my personal experience, this peptide has shown more noticeable results in skin firming and softening lines than Matrixyl and Matrixyl 3000. It is, of course, anecdotal, but it has made this peptide my favourite.***
Carrier Peptides: Delivering Essential Minerals
Carrier peptides act as mineral transporters, binding trace elements and delivering them to where the skin’s enzymes need them. The standout example is GHK-Cu (Copper Tripeptide-1).
Copper is essential for lysyl oxidase, which cross-links and stabilises collagen and elastin after synthesis. Without it, collagen is weak. GHK-Cu not only delivers copper but also stimulates collagen, elastin, and glycosaminoglycan synthesis, modulates MMP activity, and upregulates anti-inflammatory and antioxidant genes. A 12-week trial showed GHK-Cu improved collagen in 70% of participants. Naturally occurring in human plasma, GHK peaks in your 20s and declines by ~60% by age 60, giving it a unique biological role.
On ingredient lists, look for Copper Tripeptide-1 or Tripeptide-1.
Neurotransmitter-Inhibiting Peptides: The “Botox-Like” Claims
This is the most hyped peptide category and the one requiring the most scrutiny. These peptides attempt to soften expression lines by reducing the intensity of facial muscle contractions.
Acetyl hexapeptide-8, sold as Argireline, mimics part of SNAP-25 to reduce muscle contraction signals.
Although SNAP-25 inhibition has been demonstrated in cell systems, it's unclear whether topically applied Argireline reaches the neuromuscular junction effectively. There is significant evidence against it.
The mechanism is real at the cellular level, and a placebo-controlled trial in 60 subjects showed significant reduction in wrinkle roughness at 4 weeks. However, a 2025 systematic review in the International Journal of Molecular Sciences concluded that evidence for true neuromuscular inhibition via topical application remains limited. The neuromuscular junction is deep below the dermis; reaching it through skin is unlikely. Wrinkle improvements probably result from surface effects like hydration or superficial nerve endings, not deep muscle relaxation. “Botox in a bottle” is a claim that significantly outruns the evidence.
Pentapeptide-18 (Leuphasyl) mimics enkephalin to modulate nerve calcium channels, reducing acetylcholine release, targeting a different step in the same pathway, and combining it with Argireline has shown enhanced wrinkle reduction vs. either peptide alone in both in vitro and in vivo studies, with one trial reporting ~35% reduction in forehead wrinkle depth over 60 days. The same penetration caveat applies to all peptides in this class.
Enzyme-Inhibiting Peptides: The Defensive Strategy
This approach doesn't stimulate new collagen but blocks MMP enzymes that break it down. UV, inflammation, and ageing increase MMPs, so inhibiting them preserves existing collagen instead of creating new.
Tripeptide-10 Citrulline (Decorinyl) mimics decorin, a protein that organises collagen fibres into structured bundles and becomes dysfunctional with age. In vitro testing showed it regulates fibrillogenesis, producing thinner, more uniform collagen fibrils. A blinded, placebo-controlled study with 43 volunteers confirmed improved fibril uniformity and increased skin suppleness. The evidence is weaker than for signal peptides; most data are in vitro or supplier-backed, and effects are harder to see clinically because they measure a slowdown in degradation rather than visible new protein. Still, the logic is sound, and the strategy complements signal peptides.
Newer Generation Peptides: What’s Worth Watching
Palmitoyl Tetrapeptide-50 (X50® Hyalufiller): Promising Delivery Innovation
Most peptides are simply dissolved in a formula and hope to reach their target. X50® Hyalufiller takes a different approach: the active peptide is encapsulated in biodegradable polymer capsules coated with a targeting ligand (heptapeptide-15 palmitate) that actively seeks out and binds to fibroblasts, a concept Infinitec calls “cosmetic drone” technology. Once delivered, the peptide boosts hyaluronic acid production by inducing HAS2 enzyme expression and stimulates elastin synthesis.
The mechanism is scientifically coherent and directly addresses one of the topical peptides biggest challenges: getting to the right cells. Manufacturer testing in 20 volunteers reported a 34% reduction in deep wrinkles after 2 weeks at a 1% concentration. The honest caveat: all published data comes from Infinitec’s own studies, not independent peer-reviewed trials. Credible mechanism, encouraging numbers, but treat the efficacy claims with appropriate caution until verified externally.
Senomorphic Peptides: Targeting Ageing at Its Source
Senomorphic peptides target one aging root cause: senescent cells that stop dividing but don’t die, releasing SASP signals that damage tissue and hinder repair.
Pep 14, published in npj Aging (Nature portfolio, 2023), modulates PP2A, an enzyme governing DNA repair and cell senescence, to prevent fibroblasts from progressing into late senescence. In aged ex vivo human skin (donors aged 35–79, treated topically at 0.01% for 5 days), it reduced senescence markers (CDKN2A, H2A.J), decreased SASP (IL-6, CXCL8), increased proliferation and collagen expression, and reduced DNA methylation age by an average of 2.6 years across multiple epigenetic clocks. Critically, it outperformed retinol on all measured markers, whereas retinol caused stratum corneum peeling and increased some inflammatory markers.
This early-stage research lacks commercial availability and a finalised INCI name, with in vivo human trials pending. However, the research, published in a Nature journal and featuring validated endpoints such as epigenetic clocks, far exceeds typical cosmetic ingredient evidence, and its mechanism is unique in the mainstream skincare space.
Cyclic Peptides: Better Stability, Better Penetration
Standard peptides are linear chains susceptible to enzymatic degradation in the formula and on the skin. Cyclisation links the peptide’s head to its tail, forming a ring that makes the molecule more stable, shelf-stable, and potentially better at penetrating skin than linear peptides.
Cyclised hexapeptide-9 (CHP-9) is the best-evidenced example so far. In a 2025 randomised, double-blind, vehicle-controlled trial in ~90 participants, 0.002% CHP-9 was compared head-to-head against 0.002% retinol and a vehicle control over 56 days. CHP-9 outperformed retinol on multiple validated biomechanical parameters, including wrinkle depth, skin firmness, and roughness, with significantly better tolerability. Comparing directly against retinol, rather than just a weaker control, makes this result particularly noteworthy. But it is important to note that the study used 0.002% retinol, which is far below the concentrations (around 0.1-0.5%in cosmetics ) that have been documented to have clinical efficacy for photoageing. Results from comparisons with therapeutically effective retinol strengths might therefore be less favourable for the peptide. This is early but compelling evidence that cyclosation could represent the next meaningful leap in topical peptide efficacy.
How to Read Peptide Marketing and What to Expect
Spotting a legitimate claim:
A brand claiming its peptide “stimulates collagen production” makes a plausible claim. The key question is: has this peptide been shown to activate relevant receptors on keratinocytes or fibroblasts, and can the formulation reach the viable epidermis (where keratinocyte activation triggers signalling to fibroblasts) or better, the dermis itself, where fibroblast receptors are located?
A brand claiming it “rebuilds collagen from the outside” uses vague, scientific-sounding language that lacks precision. That’s a red flag.
Why results are subtle…and slow ( very slow ):
The matrikine system your skin uses for repair wasn’t designed for high-intensity stimulation. It evolved to respond to the low-level, background hum of normal tissue turnover. Topical peptides work within that same system, which means they’re tuned for gradual maintenance, not dramatic reconstruction. And it only becomes slower with age…
This isn’t a flaw. It’s just what the biology supports, and it sets realistic expectations:
Most signal peptides need at least 12 weeks of consistent use ( twice daily ) before visible improvements emerge, which aligns with the natural cycle of dermal collagen turnover. For the skin over 45, it may take even longer ( up to 120 days )
GHK-Cu may show some improvement from around 4–6 weeks, with continued gains beyond 12 weeks.
If a product promises a visible transformation in days, that timeline doesn’t match what the underlying biology can actually deliver. Cumulative, progressive improvement is a realistic, evidence-based outcome.
Why Multi-Peptide Strategies Have Earned Their Place
A 2025 clinical study combining seven bioactive peptides with silybin (a plant-derived compound from Silybum marianum) demonstrates the multi-peptide principle in action. In vitro assays showed that the combination rapidly upregulated collagen types I, III, IV, and XVII, as well as lysyl oxidase (the enzyme responsible for collagen cross-linking), within 4-16 hours. In a 56-day clinical study with 31 participants, instrumental measurements showed improvements in elasticity (+12.5%), firmness (+20.7%), and dermal density (+78%).
Targeting multiple collagen types and the cross-linking enzyme together offers a more comprehensive approach than single-pathway strategies, supporting well-designed multi-peptide formulations. Full study details, including vehicle control use, aren’t publicly available, but results align with expectations.
The Concentration Question And Why It’s Not Simple
You may have heard ‘the rule’: if a product contains lots of peptides without disclosing concentrations, it’s probably using token “dusting” amounts for label appeal rather than real efficacy. This concern is legitimate, but it’s not the whole story.
For a peptide to produce a biological effect, it needs to reach its target receptors at a sufficient concentration to trigger a cellular response. Below a minimum threshold, nothing meaningful happens, regardless of how prominently the ingredient features in the marketing. For well-researched signal peptides, that threshold sits in the very low parts-per-million range. The pivotal Robinson et al. (2005) 12-week, vehicle-controlled RCT demonstrated significant wrinkle reduction with Matrixyl at just 3 ppm, which corresponds to 0.0003% of the finished product. When brands include peptides below this low bar just to meet labelling rules, not for scientific reasons, it's consumer misdirection.
However, and this is a nuance that often gets lost, even genuinely effective peptides at 3 ppm will always sit below preservatives on an ingredient list. Preservatives like phenoxyethanol are used at 0.4–1%, while 3 ppm represents 0.0003%. By law, ingredients are listed in descending order of concentration down to 1%, below which they can appear in any order. This means a position below the preservative system tells you almost nothing on its own about whether a peptide is dosed appropriately. A more meaningful red flag is when peptides are placed at the end of a very long list, after colourants, fragrances, and botanical extracts, where the chance of insignificant, sub-ppm inclusion increases.
Here’s where the science becomes genuinely interesting.
Products containing many peptides ( like Numbuzin for example ) at individually sub-optimal concentrations are not automatically ineffective. Skin cells don’t evaluate incoming signals the way a pharmacologist models a single receptor’s dose-response curve. Fibroblasts and keratinocytes evolved to read their entire chemical environment simultaneously and make decisions based on the composite pattern of everything they’re receiving at once. Different peptides act at different receptor sites and at different points along converging collagen-synthesis pathways, TGF-β receptors, integrin receptors, and MMP-TIMP checkpoints.
If enough connected networks fire together, the whole system hits a threshold to trigger a result that no single peptide acting alone would achieve.
This is a well-established principle in cell signalling biology, not a marketing argument. It also explains why results with such formulas tend to be progressive, building over weeks of consistent use rather than appearing quickly.
Delivery: The Factor That Decides Whether Any of This Matters
You could pick the perfect peptides at exactly the right concentrations and still end up with a product that does very little, if those peptides never actually reach the skin cells they’re meant to signal. Delivery is arguably the most important variable in peptide formulation, and the least understood by consumers.
Why getting into skin is harder than it sounds
The outermost layer of skin, the stratum corneum, is a tightly packed lipid barrier whose entire job is to keep things out. Most peptides are water-soluble and electrically charged at skin pH, which makes them fundamentally incompatible with this lipid environment. The result: most peptides applied to skin simply sit on the surface rather than penetrating to the fibroblasts they need to reach. Different peptide classes also require different penetration depths; signal peptides need to reach the viable epidermis or dermis, while enzyme-inhibiting peptides may only need to reach the upper dermis. Delivery isn’t a single target; it varies by what you’re trying to achieve.
Palmitoylation: the delivery built into the ingredient itself
The most common and elegant solution is palmitoylation, which involves attaching a 16-carbon fatty acid (palmitic acid) directly to the peptide. This gives an otherwise water-loving peptide a lipid-compatible “anchor” that inserts into the skin’s lipid barrier, pulling the peptide through with it. Molecular dynamics simulations confirm that palmitoylated peptides show approximately 2.7× higher diffusivity across the stratum corneum lipid bilayer compared to their unmodified equivalents. In practice, palmitoyl hexapeptide-12 has been shown to penetrate beyond the stratum corneum into the epidermis, reaching depths of over 100 μm in ex vivo human skin.
This is why “palmitoyl” appearing before a peptide name, palmitoyl pentapeptide-4, palmitoyl tripeptide-1, palmitoyl hexapeptide-12, is a genuine quality indicator, not just naming convention. It tells you the ingredient has been chemically modified specifically to improve skin penetration. It doesn’t solve every delivery challenge, but it represents a rational, evidence-backed starting point.
Delivery System Two: Liposomes
Liposomes are the most clinically studied dedicated delivery technology in cosmetic science. The concept is elegant: phospholipids, which form cell membranes, spontaneously assemble into hollow spheres in water. Hydrophilic peptides, which struggle to cross the skin’s lipid barrier, are encapsulated in these capsules aqueous core and carried toward the skin as protected cargo. Liposomes are effective for skin delivery because the skin’s lipids recognise and interact with phospholipid bilayers, slowly releasing ingredients as the tiny capsules squeeze between skin cell gaps. The most common liposomal phospholipid, phosphatidylcholine, is also a mild penetration enhancer in its own right, and is metabolised within the skin into ceramide precursors, meaning the delivery vehicle actively supports barrier health as it degrades.
More advanced versions overcome conventional liposomes limited penetration depth by engineering their membranes. Ultradeformable liposomes (transfersomes) incorporate edge-activating surfactants like sodium cholate that make the vesicle membrane flexible rather than rigid, allowing it to squeeze through intercellular gaps smaller than its own diameter. Ethosomes achieve similar flexibility by incorporating 20–45% ethanol, which simultaneously fluidises the vesicle membrane and disrupts stratum corneum lipid packing, resulting in substantially improved skin permeation for peptide actives compared to conventional liposomes.
How to spot liposomal delivery on an ingredient list: the vesicle structure itself doesn’t appear; only its component phospholipids do. Look for Lecithin, Hydrogenated Lecithin, or Phosphatidylcholine appearing relatively high in the list, often near Glycerin and the peptide ingredients. This phospholipid-glycerin-peptide cluster, particularly when it corresponds to a named ingredient technology from suppliers like Lucas Meyer, Lipoid, or Evonik, is a strong indicator that the peptide was pre-encapsulated in a liposomal carrier before being added to the formula.
Delivery System Three: Nanostructured Lipid Carriers (NLCs)
NLCs are the next generation of lipid-based delivery, and for peptide actives specifically, they often outperform conventional liposomes on stability and bioavailability. Where a liposome is a hollow sphere with a lipid shell, an NLC is a solid lipid nanoparticle: think a tiny lipid droplet rather than a lipid bubble, with the peptide dispersed or dissolved within the lipid matrix itself rather than in an aqueous interior.
NLCs are made by blending solid lipids (such as cetyl palmitate or glyceryl behenate) with liquid lipids (such as caprylic/capric triglyceride or squalane). This imperfect, mixed-lipid matrix holds the active ingredient more reliably than solid particles and releases it gradually as enzymes in the skin break it down. The lipid matrix protects the peptide backbone from hydrolysis and oxidation in water, offering an advantage over liposomes for sensitive peptides. Studies confirm NLCs maintain active ingredient stability significantly better than nanoemulsion or oil solution over 180-day shelf testing.
How to spot NLC delivery on an ingredient list: look for a combination of solid wax or ester components (Cetyl Palmitate, Glyceryl Behenate, Stearic Acid) alongside liquid oil components (Caprylic/Capric Triglyceride, Squalane) with a particle-stabilising surfactant (Polysorbate 80 or Lecithin) appearing in proximity to the peptide ingredients. If the brand’s marketing references “encapsulated peptides” or “lipid nanoparticles”, cross-referencing with this lipid cluster pattern in the INCI will usually confirm whether the claim holds up.
Delivery System Four: Cyclodextrins
Cyclodextrins are underappreciated but appear in more peptide products than most people realise. They are ring-shaped sugar molecules with a clever structural property: their exterior is water-soluble, but their interior cavity is hydrophobic, able to host lipid-loving molecular guests like palmitate chains.
For palmitoylated peptides, this is particularly useful. The palmitate tail fits into the cyclodextrin cavity, forming an inclusion complex. This enhances water dispersibility of the palmitoylated peptide, preventing clumping in water-based formulas, and shields the palmitate chain from oxidative degradation during shelf life. When the complex contacts skin, it dissociates, releasing the intact palmitoylated peptide at the barrier surface at high local concentration, where it can then partition into the lipid environment.
Cyclodextrins have less penetration enhancement than lipid carriers, but their stability and ability to create concentration gradients make them a key quality indicator. On ingredient lists, they appear as Hydroxypropyl Cyclodextrin, Methyl-Beta-Cyclodextrin, or simply Cyclodextrin, and their presence near a palmitoylated peptide in the ingredient list is a meaningful positive signal.
Penetration Enhancers: Ranked
Formulators use penetration enhancers, which temporarily increase skin permeability, beyond dedicated carrier systems. They are ranked by the evidence supporting peptide delivery, from most to least, not general penetration enhancement. These are not mutually exclusive in formulations; the best products typically use combinations.
1. Dimethyl Isosorbide (DMI)
The most underrated enhancer on this list. Unlike most enhancers, which modify the skin barrier from the outside, DMI acts as a cosolvent carrier: it dissolves the peptide, then penetrates the stratum corneum, pulling its cargo along. Its intermediate polarity, water-compatible enough to dissolve peptides, lipid-compatible enough to traverse the barrier, makes it uniquely suited to hydrophilic actives like peptides. Effective at 5–10%. On ingredient lists, it appears as Dimethyl Isosorbide. If it appears after the preservative system, it's likely too dilute to contribute meaningfully.
2. Ethanol (Alcohol / Alcohol Denat.)
At 20–60% concentrations, ethanol disrupts lipid packing in the stratum corneum by extracting free fatty acids and forming temporary passageways for molecules. It also acts as a co-solvent keeping peptides in solution at the skin surface. Above 60%, the barrier disruption becomes counterproductive. Best used as one part of a broader delivery strategy rather than alone.
3. Butylene Glycol and Propylene Glycol.
The workhorses of serum formulations, almost universal and effective via multiple mechanisms. They integrate into the lipid matrix of the stratum corneum, enhancing fluidity, hydrating and swelling the intercellular spaces, and boosting the thermodynamic activity of dissolved peptides, all of which promote passive processes diffusion. Both are especially effective for hydrophilic actives, such as peptides. Look for them appearing in the upper-to-mid section of the ingredient list; below 10–15%, their enhancement contribution diminishes. Butylene glycol has a modestly better tolerability profile, which explains its prevalence in prestige formulations.
4. Oleic Acid and High-Oleic Oils
Oleic acid functions through a different mechanism: it inserts into the ordered lipid layers of the stratum corneum, transforming them from a rigid, gel-like state into a more fluid one. This creates pockets that facilitate easier diffusion of molecules. The effect is localised and reversible. Appears directly as Oleic Acid, or indirectly via high-oleic oils: Squalane, Olive Fruit Oil, and Sunflower Seed Oil all contain meaningful oleic acid fractions.
5. Niacinamide
This includes an honest caveat: while its function as a peptide penetration enhancer is plausible, independent literature does not directly confirm this. At 5%, niacinamide stimulates ceramide production in keratinocytes, enhancing the structural organisation of the stratum corneum, which could potentially improve the delivery of lipid-based carriers, like liposomes. It also increases aquaporin expression and reduces inflammation that would otherwise compromise barrier integrity. The combination of mechanisms makes it a logical ingredient for formulation. It is listed on labels simply as Niacinamide.
6. Low Molecular Weight Hyaluronic Acid
Standard hyaluronic acid (above 1,000 kDa) remains on the skin surface. In contrast, low-molecular-weight HA, especially oligomeric forms below ~50 kDa, can penetrate the epidermis, with increasing evidence of absorption via CD44 receptors on keratinocytes. Combining peptides with low-molecular-weight HA may enhance receptor-mediated co-delivery. Look for Hydrolysed Sodium Hyaluronate or specific low-molecular-weight descriptors in product materials.
7. Menthol and Terpenes
Menthol interferes with stratum corneum lipid packing in a manner similar to oleic acid, but it does so at lower concentrations (1–5%) and in a more temporary way effect. A rarely used but promising option in peptide formulations with genuine potential. Appears as Menthol or within extracts like Mentha Piperita Leaf Extract.
Formulation Stability: The Invisible Variable
Even the most elegant delivery system, the most biologically sound peptide selection, and a carefully chosen penetration enhancer combination can be compromised by instability within the formula itself. This is one of the least discussed yet most practically significant factors in peptide formulation.
pH compatibility is the most crucial factor for stability. Peptides are typically stable within a pH range of about 4.5 to 6.5. Outside this range, hydrolysis driven by acids or bases, the process where water breaks peptide bonds, occurs much more rapidly. This is a practical issue because many commonly used skincare ingredients need very different pH levels to stay effective.
L-ascorbic acid requires a pH below 3.5 to prevent oxidation, but at this pH, peptide bonds hydrolyse quickly, degrading most unprotected peptides within weeks. High-concentration L-ascorbic acid products must sacrifice one active by using a higher pH or include very low peptide levels, where degradation isn’t an issue because they’re ineffective.
The rate of acid-catalysed hydrolysis varies by peptide structure. Peptides with protective N-terminal modifications, like acetylation or palmitoylation, resist acid degradation more than unmodified peptides. Although this doesn’t eliminate degradation at pH 3.5, it shows the process depends on structure, not uniform. For most cosmetic peptides, their incompatibility with L-ascorbic acid’s pH needs remains a key formulation issue.
This common skincare error is visible from the ingredient list. If high in Ascorbic Acid alongside peptides, be sceptical. If the vitamin C derivative is more stable, like Ascorbyl Glucoside, Sodium Ascorbyl Phosphate, or Ascorbyl Tetraisopalmitate, which suit peptide stability, the pH is more compatible.
All that applies to formulation, and since we are on the topic, YES, you can use a low pH vitamin C serum and then a peptide serum in the same routine. And here are three reasons why:
The kind of peptide “damage” people worry about happens slowly in the bottle over weeks, not in a few minutes on your skin.
Your skin is naturally slightly acidic and quickly buffers products, so a short contact with a low-pH vitamin C serum won’t suddenly break down your peptides.
There are no solid studies showing that using vitamin C and peptides back-to-back on skin makes either one stop working.
If you want to be extra cautious, you:
Use vitamin C in the morning and peptides at night, or
Apply vitamin C, let it sink in for a few minutes, then apply your peptide serum.
Packaging is another variable consumers can directly evaluate at the point of purchase. Several peptide classes, especially GHK-Cu, are vulnerable to light-catalysed oxidation. Copper can undergo redox reactions under UV light, degrading the peptide-copper complex. Clear glass jars are unsuitable because they expose formulas to light and air. The best packaging uses opaque or UV-filtering containers with airless pumps, blocking light and oxygen, and preventing repeated air exposure near the dispenser. A copper peptide serum in A copper peptide serum stored in clear bottles or wide jars indicates low formulation quality, not a positive sign. Clear bottles or wide jars signal poor formulation quality, just not a positive one.
Preservative system compatibility is a technical but important factor. Highly ionic systems with metal-chelating agents, such as EDTA, can interact with carrier peptides, such as GHK-Cu, by competing for copper. Formulations with phenoxyethanol/ethylhexylglycerin are usually more peptide-friendly.
Reading the INCI List: A Practical Framework
Everything covered above becomes most useful when translated into a concrete skill: being able to look at an ingredient list and extract meaningful information about delivery quality, formulation intelligence, and likely efficacy. What follows is a framework rather than a checklist, because no single indicator is definitive in isolation.
Step one: identify the peptides and their class
by looking for ingredients ending in “-peptide” or starting with “palmitoyl,” “acetyl,” “dipeptide,” “tripeptide,” “hexapeptide,” or similar prefixes. Palmitoylated peptides have built-in lipophilic delivery, showing a positive signal. Note each class: signal, carrier, neurotransmitter-inhibiting, or enzyme-inhibiting, and consider if the blend fits the product’s purpose.
Step two: assess delivery architecture
Look for the presence of phospholipid carrier signals (**Lecithin**, **Phosphatidylcholine**, **Hydrogenated Lecithin**), NLC signals (combinations of solid and liquid lipids with a small-particle stabiliser), **Dimethyl Isosorbide** (ideally positioned in the mid-range of the list), and meaningful concentrations of glycols (which should appear above or near any mid-list thickening agents to indicate working concentrations). The more of these signals present, the more delivery-conscious the formulation.
Step three: Consider compatibility red flags
. Check for **Ascorbic Acid** appearing high in the same formula as peptides, as this formulation clash should raise doubts about at least one active’s authenticity contribution. Note that vitamin C derivatives at higher pH values (Ascorbyl Glucoside, Sodium Ascorbyl Phosphate, Ascorbyl Tetraisopalmitate) do not carry this same concern. Check the packaging for opacity and dispenser type, particularly for products containing copper peptide-1. Check for excessive ingredient complexity: a product with 40 actives is usually one where nothing is at a working concentration.
Step four: evaluate the evidence claim.
If the brand makes specific clinical claims, ask whether they describe the study design, particularly whether a vehicle-controlled arm was included. Consumer perception studies are valuable but alone cannot definitively link effects to specific actives. Instrumental measurement studies (measuring skin elasticity, surface topography, or dermal density) carry more weight, but even instrumental data requires appropriate controls to distinguish active ingredient effects from vehicle effects. The gold standard is a vehicle-controlled trial with instrumental endpoints.
Step five: hold the whole picture.
No single factor is decisive. A product with three well-chosen palmitoylated signal peptides in a phospholipid delivery system containing dimethyl isosorbide and butylene glycol at working concentrations, with stable pH and appropriate packaging, supported by a peer-reviewed or properly controlled study, is as close as the cosmetic category currently offers to a well-evidenced peptide product. A product with sixty peptides, no disclosed concentrations, no vehicle-controlled study, and L-ascorbic acid on the same label sits at the other end of the credibility spectrum. Most real products occupy the interesting space in between.
Conclusion: The Framework Is More Valuable Than the List
The cosmetic peptide category will evolve with new peptides, delivery systems, and more sophisticated models of skin cell signalling. Ingredient recommendations will age, but scientific principles will remain.
The key takeaway isn’t a list of approved peptides or forbidden ingredients, but a framework for asking better questions:
Does this peptide match my biological goal?
Does the delivery system address penetration?
Are the pH and packaging compatible with the chemistry?
Does the clinical evidence distinguish the active from the vehicle?
When a product breaks the rules but works, am I updating my model or abandoning it?
Cosmetic chemistry, like all applied science, progresses through exactly that process: forming a model based on accumulated evidence, testing it against real-world outcomes, and refining it when reality disagrees. The best peptide products are built by formulators who think this way. And the best consumers are those who evaluate them with the same rigour.
That’s it for this week. I hope this article addressed some questions you might have had. If you have any questions or need further clarification, please comment below; I'll be happy to respond.
Here is a list of the best peptides currently available on the market. I have personally tried most of them and achieved good results. I regularly update this list as I discover new, promising formulas.
---
*This article reflects the current state of published cosmetic science and the author’s professional assessment as of its writing. Where clinical evidence is limited or contested, this has been noted explicitly. No product endorsements are made or implied.*
Thank you for the deep dive and detailed info. So useful to know especially about using Vitamin C and Peptides in the same routine. So helpful to see your shopmy list as well! I’ll be treating myself to Educated Mess Freeze Frame soon 🩵 very curious about that one.
Really in-depth and valuable info .. Thank you!!